Quetiapine and St Johns Wort
Supplement–drug interaction evidence from the TruthStack database.
| Severity | HIGH |
|---|---|
| Evidence Tier | Moderate |
| Interaction Type | SAFETY CONCERN |
| Mechanism | PHARMACOKINETIC |
| Last Reviewed | 2026-02-15 |
Summary
St. John's Wort strongly induces CYP3A4, the primary enzyme metabolizing quetiapine. This can reduce quetiapine levels by 50% or more, leading to treatment failure. Combination is flagged in literature. Discuss with your prescriber or pharmacist.
CYP Enzyme Profiles
Published CYP enzyme data for compounds in this interaction:
St Johns Wort: CYP1A2 inducer (moderate), CYP2C19 inducer (moderate), CYP2C9 inducer (moderate), CYP3A4 inducer (strong), P-gp inducer (strong)
API Reference
GET https://api.truthstack.co/v1/check?c1=quetiapine&c2=st_johns_wort
Open, unauthenticated. Returns JSON. Developer documentation
Related Interactions
What this page is and is not. TruthStack is an informational reference database that describes published pharmacological findings. It does not provide medical advice, diagnosis, or treatment recommendations. The information on this page reflects flags in our database and should not replace consultation with a qualified healthcare provider. Always discuss supplement-drug combinations with your prescriber or pharmacist.